🔎 Trials Near Me

መነሻ › Multiple Sclerosis › ፍሎሪዳ

በፍሎሪዳ ለMultiple Sclerosis የሚደረጉ ክሊኒካዊ ጥናቶች

ለMultiple Sclerosis የሚደረጉ 14 ጥናቶች በፍሎሪዳ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በፍሎሪዳ ውስጥ ያሉ ከተሞች

Official study text (English)

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Aqualane Clinical Research, Naples
  • USF Health, Tampa
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06782490

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

  • Neurology Associates, PA, Maitland
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07609719

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Altamonte Springs
  • TG Therapeutics Investigational Trial Site, Boca Raton
  • TG Therapeutics Investigational Trial Site, Clearwater
  • እና 7 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06433752

Clinical Applications of Advanced Ophthalmic Imaging

  • Bascom Palmer Eye Institute, Miami
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT03135327

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Neurology of Central Florida- Site Number : 8400147, Altamonte Springs
  • Aqualane Clinical Research- Site Number : 8400026, Naples
  • Neurology Associates of Ormond Beach- Site Number : 8400086, Ormond Beach
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 60 · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07325292

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • University of South Florida, Tampa
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ10 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06408259

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Neurology of Central FL Res Ctr, Altamonte Springs
  • UF Health Cancer Center, Gainesville
  • Homestead Assoc In Research Inc, Homestead
  • እና 8 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁላይ 2026 · NCT07225504

Neurologic Stem Cell Treatment Study

  • MD Stem Cells, Coral Springs
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ጁን 2026 · NCT02795052

Dry Needling in Multiple Sclerosis

  • University of South Florida, Tampa
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሜይ 2026 · NCT07615725

Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

  • Norman Fixel Institute for Neurological Diseases, Gainesville
  • University of Florida, Gainesville
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ6 ማርች 2026 · NCT07376772

Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis

  • University of St. Augustine for Health Sciences, Saint Augustine
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ20 ሜይ 2025 · NCT06981013

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

  • Mayo Clinic Jacksonville, Jacksonville
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሜይ 2025 · NCT05395624

Longitudinal Cognitive Assessment by BoCA

  • Andrey Vyshedskiy, Miami
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦገስ 2024 · NCT04114994

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።